Literature DB >> 19306471

Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.

D S Sahota1, T Y Leung, T Y Fung, L W Chan, L W Law, T K Lau.   

Abstract

OBJECTIVE: To establish normative values and distribution parameters of first-trimester maternal serum free beta-human chorionic gonadotropin (beta-hCG), pregnancy-associated plasma protein-A (PAPP-A) and fetal nuchal translucency (NT) thickness in Chinese women and to examine the effects of covariates on their levels.
METHODS: Maternal serum free beta-hCG, PAPP-A and fetal NT were measured in 9762 women presenting for first-trimester combined screening for Down syndrome at 11 to 14 weeks of gestation. Individuals' markers were converted to multiples of the median (MoM) using expected medians estimated by performing a weighted regression analysis. Multivariate regression analysis was performed to assess the influence of maternal weight, parity, ethnicity, chorionicity in twin pregnancies, smoking, insulin-dependent diabetes and mode of conception on individual marker MoM levels.
RESULTS: Both free beta-hCG and PAPP-A median values demonstrated an exponential relationship with gestational age in days. Multivariate regression analysis indicated that free beta-hCG MoM was statistically significantly dependent on maternal weight (P < 0.0001) and chorionicity in twin pregnancy (both monochorionic and dichorionic P < 0.0001), that PAPP-A MoM was dependent on maternal weight (P < 0.0001), parity (P < 0.0001), chorionicity in twin pregnancy (both monochorionic and dichorionic P < 0.0001) and mode of conception (P = 0.002), and that fetal NT-MoM was dependent on maternal weight (P = 0.0006) and mode of conception (P = 0.012).
CONCLUSION: Normative values have been generated to allow conversion of NT, free beta-hCG and PAPP-A to their MoM equivalents and correction factors have been determined to adjust for maternal and pregnancy characteristics for use in ethnic Chinese women undergoing first-trimester screening for aneuploidy. (c) 2009 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19306471     DOI: 10.1002/uog.6340

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

1.  Retrospective study evaluating the performance of a first-trimester combined screening for trisomy 21 in an Italian unselected population.

Authors:  Francesco Padula; Pietro Cignini; Diana Giannarelli; Cristiana Brizzi; Claudio Coco; Laura D'Emidio; Elsa Giorgio; Maurizio Giorlandino; Lucia Mangiafico; Marialuisa Mastrandrea; Vincenzo Milite; Luisa Mobili; Cinzia Nanni; Raffaella Raffio; Cinzia Taramanni; Roberto Vigna; Alvaro Mesoraca; Domenico Bizzoco; Ivan Gabrielli; Gianluca Di Giacomo; Maria Antonietta Barone; Antonella Cima; Francesca Romana Giorlandino; Sabrina Emili; Marina Cupellaro; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2014 Apr-Jun

2.  The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.

Authors:  Sarah Weiling Li; Angela Natalie Barrett; Leena Gole; Wei Ching Tan; Arijit Biswas; Hak Koon Tan; Mahesh Choolani
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

3.  Optimization of regional median equations of prenatal screening markers for trisomy 21 in a Chinese population.

Authors:  Liangpu Xu; Hailong Huang; Lin Zheng; Deqin He; Na Lin; Linshuo Wang; Yuan Lin
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.